Why the study?
Does dopexamine increase oxygen delivery more effectively than dobutamine in high-risk surgical patients?
Does dopexamine increase oxygen delivery more effectively than dobutamine in high-risk surgical patients?
Dopexamine allows for greater increases in oxygen delivery than dobutamine in high-risk surgical patients due to fewer dose-limiting cardiac side effects.
Answers are grounded in this paper and cite their sources.
Dopexamine increases oxygen delivery more effectively than dobutamine in high-risk surgical patients; extends RCT evidence guiding perioperative inotrope selection.
Peri-operative increase of oxygen delivery has been shown to reduce mortality in high-risk surgical patients. This study compares the effectiveness of dopexamine and dobutamine when used to increase cardiac output as part of a regimen to increase oxygen delivery. Sixteen surgical patients were randomly allocated to receive either dopexamine or dobutamine, which was increased to a stable dose defined as either oxygen delivery index > 600 ml/min/m2, or tachycardia > 20% above baseline, other dysrhythmias or angina. At this "stable" dose there were significant increases in cardiac index (2.4 +/- 0.2 vs 3.7 +/- 0.3 l/min/m2) and oxygen delivery (380 +/- 73 vs 579 +/- 40 ml/min/m2) in the dopexamine group (P < 0.05); but not the dobutamine group. Five out of eight patients receiving dopexamine and three out of eight receiving dobutamine reached target oxygen delivery. Three dobutamine patients, but no dopexamine patients, had angina or dysrhythmias. In preoperative high-risk surgical patients, dopexamine can allow greater increases in oxygen delivery than dobutamine, due to cardiac effects that limit the dobutamine infusion rate.
No takes yet. Share an insight, caveat, or question.
Boyd et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: